OptimizeRx (OPRX) Long-Term Investments (2022 - 2024)

OptimizeRx (OPRX) has 3 years of Long-Term Investments data on file, last reported at $434000.0 in Q2 2024.

• For the quarter ending Q2 2024, Long-Term Investments changed N/A year-over-year to $434000.0; the trailing twelve-month figure through Jun 2024 stood at $434000.0 (changed N/A YoY), and the FY2023 full-year result was $568000.0, down 98.98% from the prior year.
• Long-Term Investments retreated to $434000.0 in Q2 2024, from $501000.0 in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $55.9 million in Q4 2022 to a low of $434000.0 in Q2 2024.
• A 3-year average of $11.6 million and a median of $568000.0 in 2023 frame the typical range for Long-Term Investments.
• Peak annual rise in Long-Term Investments reached 98.98% in 2023, while the deepest fall reached 98.98% in 2023.
• Tracing OPRX's Long-Term Investments over 3 years: stood at $55.9 million in 2022, then sank by 98.98% to $568000.0 in 2023, then slipped by 23.59% to $434000.0 in 2024.
• Business Quant data shows OPRX's Long-Term Investments at $434000.0 in Q2 2024, $501000.0 in Q1 2024, and $568000.0 in Q4 2023.